Drugs Made In America Acquisition Corp.
DMAA- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002028614
No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $124.9M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Drugs Made In America Acquisition Corp. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- 0 vs. Q4 2025
- Shares held
- 22.9M
- +229.2K (+1.0%) vs. Q4 2025
- Total value
- $237.3M
- +$5.27M (+2.3%) vs. Q4 2025
- New holders
- 6
- 7 more added
- Sold out
- 6
- 7 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMAA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $124.9M |
| Q1 2026 | 39 | $237.3M |
| Q4 2025 | 39 | $232.1M |
| Q3 2025 | 37 | $223.4M |
| Q2 2025 | 32 | $212.3M |
| Q1 2025 | 24 | $171.3M |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Drugs Made In America Acquisition Corp.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 58 | $608 | 0.00% | −63−52.1% | Reduced |
| Citadel Advisors LLC | 10,476 | $110.0K | 0.00% | +10,476 | New |
| BNP Paribas Arbitrage, SA | 14,737 | $154.4K | 0.00% | +14,737 | New |
| HRT Financial LP | 27,487 | $288.0K | 0.00% | −795−2.8% | Reduced |
| Lineage Point Capital LP | 31,840 | $334.2K | 0.08% | 00.0% | Unchanged |
| Dakota Wealth Management | 36,400 | $381.5K | 0.01% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 49,881 | $523.3K | 0.00% | +60+0.1% | Added |
| Periscope Capital Inc. | 50,000 | $524.8K | 0.09% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 62,273 | $653.9K | 0.00% | +16,625+36.4% | Added |
| Warberg Asset Management LLC | 92,054 | $966.1K | 0.28% | −10.0% | Reduced |
| DLD Asset Management, LP | 100,559 | $1.05M | 0.11% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 119,686 | $1.25M | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 354,048 | $1.30M | 0.01% | +28,075+8.6% | Added |
| Sona Asset Management (US) LLC | 162,795 | $1.71M | 0.07% | +162,795 | New |
| L1 Global Manager Pty Ltd | 200,000 | $2.10M | 1.69% | 00.0% | Unchanged |
| Toronto Dominion Bank | 203,838 | $2.14M | 0.00% | +3,838+1.9% | Added |
| Governors Lane LP | 250,000 | $2.62M | 0.33% | 00.0% | Unchanged |
| Context Capital Management, LLC | 250,000 | $2.62M | 0.06% | 00.0% | Unchanged |
| Quarry LP | 266,551 | $2.80M | 0.56% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 297,833 | $3.13M | 0.02% | −1,252,167−80.8% | Reduced |
| RLH Capital LLC | 316,551 | $3.32M | 1.69% | +316,551 | New |
| CNH Partners LLC | 357,585 | $3.75M | 0.06% | −13,626−3.7% | Reduced |
| Meteora Capital, LLC | 380,299 | $3.99M | 0.29% | +380,299 | New |
| Whitebox Advisors LLC | 400,000 | $4.19M | 0.06% | 00.0% | Unchanged |
| Rivernorth Capital Management, LLC | 417,998 | $4.38M | 0.22% | 00.0% | Unchanged |
| LMR Partners LLP | 500,000 | $5.24M | 0.05% | 00.0% | Unchanged |
| Radcliffe Capital Management, L.P. | 546,808 | $5.74M | 0.43% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 550,000 | $5.76M | 0.24% | +347,931+172.2% | Added |
| Heights Capital Management, Inc | 650,000 | $6.83M | 1.91% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 690,000 | $7.25M | 0.01% | 00.0% | Unchanged |
| Aristeia Capital LLC | 881,716 | $9.24M | 0.21% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | 1,323,351 | $13.9M | 0.88% | +1,323,351 | New |
| Wolverine Asset Management LLC | 1,553,708 | $16.3M | 0.25% | +246,240+18.8% | Added |
| Polar Asset Management Partners Inc. | 1,600,000 | $16.8M | 0.40% | 00.0% | Unchanged |
| Westchester Capital Management, LLC | 1,669,000 | $17.5M | 0.85% | 00.0% | Unchanged |
| Glazer Capital, LLC | 1,678,406 | $17.6M | 0.37% | −138,022−7.6% | Reduced |
| Mizuho Securities USA LLC | 2,000,000 | $20.9M | 0.49% | +566,517+39.5% | Added |
| Vivaldi Asset Management, LLC | 2,242,500 | $23.5M | 1.23% | 00.0% | Unchanged |
| Karpus Management, Inc. | 2,530,517 | $26.5M | 0.83% | −8,125−0.3% | Reduced |
| Mercuria Capital Strategies, LLC | 0 | $0 | 0.00% | −750,000−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −346,154−100.0% | Sold out |
| Bulldog Investors, LLP | 0 | $0 | 0.00% | −130,264−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −38,159−100.0% | Sold out |
| Logan Stone Capital, LLC | 0 | $0 | 0.00% | −10,900−100.0% | Sold out |